These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 29925504)
1. LDHA in Neuroblastoma Is Associated with Poor Outcome and Its Depletion Decreases Neuroblastoma Growth Independent of Aerobic Glycolysis. Dorneburg C; Fischer M; Barth TFE; Mueller-Klieser W; Hero B; Gecht J; Carter DR; de Preter K; Mayer B; Christner L; Speleman F; Marshall GM; Debatin KM; Beltinger C Clin Cancer Res; 2018 Nov; 24(22):5772-5783. PubMed ID: 29925504 [No Abstract] [Full Text] [Related]
2. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma. Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046 [TBL] [Abstract][Full Text] [Related]
4. Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha. Qing G; Skuli N; Mayes PA; Pawel B; Martinez D; Maris JM; Simon MC Cancer Res; 2010 Dec; 70(24):10351-61. PubMed ID: 20961996 [TBL] [Abstract][Full Text] [Related]
5. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival. Mack N; Mazzio EA; Bauer D; Flores-Rozas H; Soliman KF Anticancer Res; 2017 Mar; 37(3):1205-1212. PubMed ID: 28314283 [TBL] [Abstract][Full Text] [Related]
7. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression. Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517 [TBL] [Abstract][Full Text] [Related]
8. Dzieran J; Rodriguez Garcia A; Westermark UK; Henley AB; Eyre Sánchez E; Träger C; Johansson HJ; Lehtiö J; Arsenian-Henriksson M Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1229-E1238. PubMed ID: 29374092 [TBL] [Abstract][Full Text] [Related]
9. MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation. Delaidelli A; Negri GL; Jan A; Jansonius B; El-Naggar A; Lim JKM; Khan D; Oo HZ; Carnie CJ; Remke M; Maris JM; Leprivier G; Sorensen PH Cell Death Differ; 2017 Sep; 24(9):1564-1576. PubMed ID: 28574509 [TBL] [Abstract][Full Text] [Related]
10. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression. Zhao X; Li D; Pu J; Mei H; Yang D; Xiang X; Qu H; Huang K; Zheng L; Tong Q Oncogene; 2016 Jul; 35(27):3565-76. PubMed ID: 26549029 [TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor pathway promotes glycolysis by activating LDHA and suppressing LDHB in a STAT1-dependent manner in prostate cancer. Ye Y; Yang F; Gu Z; Li W; Yuan Y; Liu S; Zhou L; Han B; Zheng R; Cao Z J Transl Med; 2024 May; 22(1):474. PubMed ID: 38764020 [TBL] [Abstract][Full Text] [Related]
12. Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma. Sahu D; Hsu CL; Lin CC; Yang TW; Hsu WM; Ho SY; Juan HF; Huang HC Oncotarget; 2016 Sep; 7(36):58022-58037. PubMed ID: 27517149 [TBL] [Abstract][Full Text] [Related]
13. Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism. Ždralević M; Brand A; Di Ianni L; Dettmer K; Reinders J; Singer K; Peter K; Schnell A; Bruss C; Decking SM; Koehl G; Felipe-Abrio B; Durivault J; Bayer P; Evangelista M; O'Brien T; Oefner PJ; Renner K; Pouysségur J; Kreutz M J Biol Chem; 2018 Oct; 293(41):15947-15961. PubMed ID: 30158244 [TBL] [Abstract][Full Text] [Related]
14. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features. Tajiri T; Liu X; Thompson PM; Tanaka S; Suita S; Zhao H; Maris JM; Prendergast GC; Hogarty MD Clin Cancer Res; 2003 Aug; 9(9):3345-55. PubMed ID: 12960121 [TBL] [Abstract][Full Text] [Related]
15. KAP1 stabilizes MYCN mRNA and promotes neuroblastoma tumorigenicity by protecting the RNA m Yang Y; Zhang Y; Chen G; Sun B; Luo F; Gao Y; Feng H; Li Y J Exp Clin Cancer Res; 2024 May; 43(1):141. PubMed ID: 38745192 [TBL] [Abstract][Full Text] [Related]
16. miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect. Li L; Kang L; Zhao W; Feng Y; Liu W; Wang T; Mai H; Huang J; Chen S; Liang Y; Han J; Xu X; Ye Q Cancer Lett; 2017 Aug; 400():89-98. PubMed ID: 28461244 [TBL] [Abstract][Full Text] [Related]
17. The survivin-ran inhibitor LLP-3 decreases oxidative phosphorylation, glycolysis and growth of neuroblastoma cells. Galiger C; Zohora FT; Dorneburg C; Tews D; Debatin KM; Beltinger C BMC Cancer; 2023 Nov; 23(1):1148. PubMed ID: 38007466 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification. Xu Y; Chen X; Lin L; Chen H; Yu S; Li D Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710 [TBL] [Abstract][Full Text] [Related]
19. RNA N Cheng J; Xu L; Deng L; Xue L; Meng Q; Wei F; Wang J Sci Rep; 2020 Aug; 10(1):13624. PubMed ID: 32788584 [TBL] [Abstract][Full Text] [Related]
20. The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer. He TL; Zhang YJ; Jiang H; Li XH; Zhu H; Zheng KL Med Oncol; 2015 Jul; 32(7):187. PubMed ID: 26021472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]